000 | 00965 a2200265 4500 | ||
---|---|---|---|
005 | 20250517110737.0 | ||
264 | 0 | _c20180502 | |
008 | 201805s 0 0 eng d | ||
022 | _a1945-7197 | ||
024 | 7 |
_a10.1210/jc.2016-2343 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSugiyama, Toshihiro | |
245 | 0 | 0 |
_aLetter to the Editor: Combination Treatment With Teriparatide and Denosumab in Osteoporosis. _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _c08 2016 |
||
300 |
_aL80-1 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aBone Density Conservation Agents |
650 | 0 | 4 | _aDenosumab |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOsteoporosis |
650 | 0 | 4 | _aTeriparatide |
700 | 1 | _aOda, Hiromi | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 101 _gno. 8 _gp. L80-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2016-2343 _zAvailable from publisher's website |
999 |
_c26293165 _d26293165 |